Calypte Biomedical Corp (CBMC) financial statements (2022 and earlier)

Company profile

Business Address 5000 HOPYARD ROAD, SUITE 480
PLEASANTON, CA 94588
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15
Cash and cash equivalents15
Receivables4
Inventory, net of allowances, customer advances and progress billings156
Inventory156
Prepaid expense24
Total current assets:199
Noncurrent Assets
Property, plant and equipment22
Intangible assets, net (including goodwill)1,531
Intangible assets, net (excluding goodwill)1,531
Other noncurrent assets14
Total noncurrent assets:1,567
TOTAL ASSETS:1,766
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,062
Employee-related liabilities41
Other undisclosed accounts payable and accrued liabilities2,021
Debt79
Other undisclosed current liabilities1,112
Total current liabilities:3,253
Noncurrent Liabilities
Other undisclosed noncurrent liabilities3,776
Total noncurrent liabilities:3,776
Total liabilities:7,029
Temporary equity, carrying amount3,776
Stockholders' equity
Stockholders' equity attributable to parent(5,263)
Common stock16,163
Additional paid in capital159,755
Accumulated other comprehensive loss(1)
Accumulated deficit(181,180)
Other undisclosed stockholders' equity(3,776)
Total stockholders' equity:(9,039)
TOTAL LIABILITIES AND EQUITY:1,766

Income statement (P&L) ($ in thousands)

12/31/2012
Revenues
(Revenue, Net)
230
Cost of revenue
(Cost of Goods and Services Sold)
(216)
Gross profit:14
Operating expenses(1,185)
Other undisclosed operating income216
Operating loss:(955)
Interest and debt expense(122)
Other undisclosed income from continuing operations before equity method investments, income taxes1
Net loss available to common stockholders, diluted:(1,076)

Comprehensive Income ($ in thousands)

12/31/2012
Net loss:(1,076)
Comprehensive loss, net of tax, attributable to parent:(1,076)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: